These observations suggest that cell-free miR200s are not only promising biomarkers in the non-invasive diagnostics of ovarian cancer but might provide information about the pathophysiology of the tumor cells as well (e.g., ERα expression and estrogen responsiveness). Here, ESR1 is linked to ovarian cancer.